Home Search

healthcare - search results

Not happy with your results? Use the filtering tools to tailor your search
2020 was going to be the year that more mega firms got into the secondaries business. Has covid-19 put a stop to that? Here’s today's brief, for our valued subscribers only.
Global tech
The mid-market firm has wrapped up fundraising for its eighth flagship fund, gathering more than €1bn in commitments.
Eurazeo raises €400 million (Fundraiser)
The Netherlands firm closed its fifth venture capital fund.
Chemist in lab
Foreign PE firms looking to acquire healthcare-related companies in Europe can expect another three months of FDI review added to the deal process.
Pharmaceutical business
The Singaporean firm held the final close on Quadria Capital Fund II on $595m after raising its hard-cap from $500m, managing partner Abrar Mir tells PEI.
Chinese pharmacy
Deal sourcing will be led by Peng Fu, a former MD at Chinese investment manager Fosun, according to an investor email seen by PEI.
Eurazeo raises €400 million (Fundraiser)
The American manager closes its fourth flagship fund.
DNA cell
Specialist healthcare manager GHO has raised €975m for its second vehicle, the largest-ever European fund dedicated to healthcare and life sciences.
The Houston-based growth equity firm closed its latest healthcare technology fund.
The Toronto, Canada-headquartered healthcare private equity investor closes fifth fund above target.

healthcare - database search results


Copyright PEI Media

Not for publication, email or dissemination

Added to your Saved Articles
Unsave Article
Please confirm you would like to remove this article from your saved articles.
Share with other subscribers
Only logged in subscribers of this site will be able to access the shared article.